Heated chemo meets targeted drug in bold ovarian cancer fight
NCT ID NCT07460180
Summary
This study is testing whether adding a targeted drug called olaparib to a specialized surgery improves outcomes for advanced ovarian cancer. During surgery, doctors wash the abdomen with heated chemotherapy (HIPEC). Researchers want to see if taking olaparib pills for a week before this surgery makes the treatment more effective without causing severe side effects. The trial will enroll up to 55 patients to find the safest drug dose and gather early evidence on whether this approach helps.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NKI-AvL
RECRUITINGAmsterdam, 1066CX, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.